A Win For Diffusion Pharmaceuticals Inc.
Wed, Nov 20, 2019 at 05:30 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) rocketted today at $0.37, representing a gain of 67.6%. On Tue 19 Nov 19, DFFN:NASDAQ touched a New 2-Week Low of $0.22. The stock featured on our News Catalysts scanner on Wed 20 Nov 19 at 02:28 PM. From Wed 30 Oct 19, the stock recorded 21.43% Up Days and 13.33% Green Days
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Cancer Genetics, Inc. (CGIX:NASDAQ), 131.25%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 105.56%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 67.59%
- Aravive, Inc. (ARAV:NASDAQ), 48.08%
- Surface Oncology, Inc. (SURF:NASDAQ), 38.19%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 33.05%
- Amira Nature Foods Ltd. (ANFI:NYSE), 29.89%
- Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 28.67%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 25.21%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 25.15%